糖心视频

Morning Report:听Robinhood, already a unicorn, is bringing fee-free crypto trading to the market today after over a million people signed up for its waitlist. Does it matter?

After a considerable public waiting period, Robinhood started to roll its commission-free听crypto trading to select users in five states. The release comes after sustained media interest in the product’s growing waitlist, which eventually topped one million individuals.

Follow Crunchbase News on &

Robinhood, best known for its commission-free stock trading tools, is moving into crypto after the 2017 bitcoin mania has partially subsided. Prices of bitcoin are off around half from their all-time-highs, and other tokens and cryptocurrencies have marked similar declines.

Born in 2013,听, Robinhood has raised at least $176 million to date, including a , which gave the company a $1.2 billion pre-money valuation.

Without losing ourselves in the question of whether adding crypto to personal portfolios instead of traditional assets is intelligent鈥攈ere’s a听鈥攚hat makes the Robinhood move interesting is its contra-Coinbase potential. Coinbase has emerged as a leading player in the crypto purchase, storage, and trading spaces in the United States. Robinhood wants a piece of that market and at a potential cost-advantage.

Thus whether or not Robinhood’s newly launched product can undercut Coinbase’s stellar, recent growth is the question. It’s unicorn v. unicorn.

听From The听:

• , a direct-to-consumer beauty products company, has closed on $52 million in a Series C funding round led by IVP and Index Ventures.

Drone startups flying high

• Over the past eight years, drone companies have raised nearly $1.8 billion dollars, with about a third of that coming in the past fourteen months. To keep up as the space heats up, Crunchbase News assembled a list of the top early stage drone startups to watch.

• , a Toronto-based online wealth management startup, has raised $51 million from Power Financial Corp. To date, the four-year-old startup has raised nearly $130 million.

Evelo Bio raises $47.5M

• , a developer of therapeutics based around the human microbiome, has raised $47.5M in fresh funding, according to a securities filing. The funding brings total capital raised by the Cambridge, Mass.-based company to over $130 million.